| Upgrades | Mkt Perform Outperform | X | ||
| Upgrades | Neutral Buy | X | ||
|
$13 $27 |
||||
| Downgrades | Buy Hold | X | ||
|
$40 $12 |
||||
| Downgrades | Outperform Mkt Perform | X | ||
|
$38 $18 |
||||
| Downgrades | Outperform Mkt Perform | X | ||
|
$35 $15 |
||||
| Resumed | Outperform | X | ||
| Initiated | Sell | X | ||
QTRX Quanterix Corporation
Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ
Quanterix Corporation is a United States-based company, which develops tools for high definition diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. The Company offers Simoa HD-1 analyzer, which creates high density arrays of approximately 40 femtoliter microwells. Its Simoa HD-1 analyzer is an automated immunoassay platform with multiplexing and custom assay capability. The Company offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. It offers a range of complete assay kits, including multiplex panels, covering a range of therapeutic areas. Its services include Simoa Accelerator Lab and custom assay development services.
